P E R S O N A L I Z E
“And it ought to be remembered that there is nothing more difficult to take in hand, more perilous to conduct, or
more uncertain in its success, than to take the lead in the introduction of a new order of things.”
Niccolò Machiavelli, The Prince
M E D I A K I T 2 0 1 7
Field Notes 2 short reports on new trends or developments in the Precision Medicine Field
Precision ToolsA review of the current tools and technologies that are enabling a deeper insight
into the mechanism of various diseases.
SNPshot A focus on a particular disease area and progress being made in the
advancement of new Precision Therapies.
Cognoscienti There are many important cogs that need to work in unison to drive the Precision Medicine
movement forward. We curate opinion from the thinkers in the fields of regulation, bioethics, health economics, policy and education.
The Hub A report on a region that is building public/private partnerships and promoting inward
investment to further the advancement of Precision Medicine.
2020We talk to a visionary about their career path in science, how it has shaped
their current perspective in this evolving field and ask for some predictions for the future of Precision Medicine.
1
2
4
5
Bi-Monthly Features
‘I believe the clinical application of precision medicine has the ability to positively impact patients across an array of medical disciplines. As precision medicine becomes an increasingly critical treatment paradigm,
physicians and providers throughout the world are seeking for sources of information on this topic. I believe the Journal of Precision Medicine has the opportunity to fill a significant
need in this regard and I am excited to participate on the Board.’
3
P E R S O N A L I Z E
6
Lincoln Nadauld Director, Cancer Genomics, Intermountain Healthcare
Jonathan KnowlesEx Head Global Pharma Research
RocheChairman Immunocore
Mark FidockVP Head of Personalized
Healthcare and Biomarker LabsAstra Zeneca
Anick DuboisDirector Personalized Medicine
Implementation CEPMED (Center of Excellence in Personalized Medicine)
Montreal Heart Institute
Edgar BraendleCEO & President ARUP Laboratories
Professor Gillies MckennaHead of Department of Oncology
Director CRUK/MRC Oxford Institute for Radiation Oncology
Katherine Johansen TaberDirector of Personalized Medicine
American Medical Association
Kathryn PhillipsProfessor of Health Economics and Health Services
Research Founder/Director of the UCSF Center for Translational and Policy Research
on Personalized Medicine (TRANSPERS)
Frank PrendergastFormer Director of Individualized Medicine Institute
Mayo Clinic
Marielena MataProgram Director, Precision Medicine and
Companion Diagnostics, GSK
Boris PascheDirector, Comprehensive Cancer Center and
Chairman, Department of Cancer Biology, Wake Forest University
Scott V. McGoohanDirector, Science and Regulatory Affairs
Biotechnology Industry Organization (BIO)
George PosteChief Scientist, Complex Adaptive Systems
at Arizona State University
David KlonoffMedical Director, Diabetes Research Institute,
Mills-Peninsula Health Services (Sutter Health)
Stephen NaylorFounder, Chairman, President Mai Health,
Indianapolis, IN
Deepak AsudaniAssociate Clinical Professor of Medicine
University of California, San Diego
Raymond McCauleyChair Biotechnology and Bioinformatics,
Singularity University
Catalina Lopez-CorreaChief Scientific Officer & Vice President
Genome British Columbia
Advisory Board Members
P E R S O N A L I Z E
Atul J. ButteDirector, Institute for Computational Health Sciences and Professor of PediatricsUniversity of California, San Francisco
Mark A. RubinDirector, Englander Institute for Precision Medicine at Weill Cornell Medicine
Dennis LoDirector of the Li Ka Shing Institute of Health Sciences, Li Ka Shing Professorof Medicine and Professir of Chemical Pathology of The Chinese University of Hong Kong
Stephen KingsmorePresident/CEO, Rady Pediatric Genomic and Systems Medicine Institute
Rupert VesseyPresident, Research & Early DevelopmentCelgene Corporation
Mara G. AspinallPresident and CEO of HealthCatalysts
Geoffrey S. GinsburgDirector Center for Applied Genomics and Precision Medicine, Duke University Medical Center
Hakan SakulVice President and Head of Diagnostics at Pfizer
Vincent FunariTechnical Director and Director of Bioinformatics for Molecular Lab at NeoGenomics Laboratories
Nicholas DracopoliVice President, Head Oncology Translational Research at Janssen R&D, Johnson & Johnson
Dietrich StephanChair of the Department of Human Genetics at the University of Pittsburgh, Graduate School of Public Health
Patrick TanSenior Group Leader, Genome Institute of Singapore, Senior Principal Investigator, Cancer Science Institute of Singapore
Isidore RigoutsosDirector - Computational Medicine, Sidney Kimmel Cancer Center,. Thomas Jefferson University
Jennifer Levin CarterFounder, N of One
Lincoln NadauldDirector, Cancer Genomics, Intermountain Healthcare
Eric LaiSenior VP, Head of Pharmacogenomics & Companion Diagnostics, Takeda Pharmaceuticals International, Inc.
Emanuel Petricoin IIIUniversity Professor at George Mason University, Co-Director Center for Applied Proteomics and Molecular Medicine
James CzabanChair, FDA Practice Group DLA Piper
14,500
8,500
2,000
US
A
Eu
rop
e
R o
f W
Geographical Breakdown
Total circulation 25,000*
USA
EUROPE
REST OF THE WORLD
P E R S O N A L I Z E*15,000 print and 10,000 digital
Industry 38%
Acade
mic 22%
Clinical 32%
Go
vern
men
t 5
%
Oth
er 3
%
Institution
Industry 38% Pharma/BioPharm/Biotech/CRO’s
Clinical 32% Hospitals, Independent Labs, Core Labs, Reference Labs, CLIA Labs
Academic 22% Centers of Excellence, Precision Medicine Institutes, Universities, Research Institutes
Government 5% Regulatory Bodies, Institutions, Policy Makers
Other 3% Healthcare Providers/ Healthcare Agencies/ Patient Advocate Groups
P E R S O N A L I Z E
A U G U S T 2 1 - 2 4 , 2 0 1 7 H I L T O N S A N D I E G O B A Y F R O N T
2 N D A N N U A L P R E C I S I O N M E D I C I N E L E A D E R S S U M M I T
“It was exciting to participate in the first Precision Medicine Leaders’ Summit. The Journal of Precision Medicine gathered many pioneers in the field and created
an open and candid forum to discuss the advancement of precision medicine. We not only covered current FDA and Congressional thinking on diagnostics, but also had the opportunity to explore forward-looking policies that would
help ensure the full realization of precision medicine. I’ll definitely be back next year and look forward to reconnecting with many of these innovators.”
Wade Ackerman, Partner in the Food, Drug, and Device Group at Covington & Burling LLP
A U G U S T 2 1 - 2 4 , 2 0 1 7 H I L T O N S A N D I E G O B A Y F R O N T
2 N D A N N U A L P R E C I S I O N M E D I C I N E L E A D E R S S U M M I T
The 2nd Annual Precision Medicine Leaders’ Summit offers sponsorship and exhibiting opportunities to companies or organizations wishing to reach
key decision makers in the Precision Medicine field. There are a limited number of these varied offerings. To obtain more information please contact
Damian Doherty at [email protected] orNigel Russell at [email protected]
INDUSTRY
ACADEMIC
CL IN ICAL
GOVERNMENT
OTHER
P E R S O N A L I Z E
38%22%32%
AbbVie Research Fellow
Abbvie, Inc. Associate Scientific Director
Abbvie, Inc. Director
Acetylon Pharmaceuticals CMO & SVP Clinical Development
Affimed Therapeutics Chief Medical Officer
Agios Pharmaceuticals Vice President - Chemistry
Alexion VP Clin Ops
Amgen Inc. Director Preclinical
Amgen Inc. Exec Medical Dir Med Sciences
Ariad Pharmaceuticals Experimental/Computational Biologist
ARUP Laboratories Medical Director and Professor
AstraZeneca Translational Genomics Lead
AstraZeneca VP, Immuno-Oncology
AstraZeneca Canada Inc. Medical Advisor Oncology; Urology and Infection
AstraZeneca Bioscience Director
AstraZeneca R&D Boston Executive Director
ASU Chief Scientist
Avera Health Cancer Genomics Investigator
Basilea Pharmaceutica International Ltd. Head of Cancer Biology
Bayer Healthcare Global Clinical Leader
Bayer Pharma Ag Head Global Biomarker Strategy
Baylor College of Medicine Director
Biothera, Inc. Vice President Immunology
BMS SVP Head of Development Oncol
Brigham And Women’s Hosp. Clinical Fellow
Bristol-Myers Squibb Group Director; Pharmacodiagnostics
Bristol-Myers Squibb Director of Biostatistics
Bristol-Myers Squibb Company Group Medical Director
Broad Institute of MIT & Harvard Director; Genomics R&D and Clinical Development
Cancer Treatment Centers of America Senior Vice President; Personalized Medicine Operations
Catholic Health Initiatives Informatics Data Scientist
Cedars-Sinai Health System Vice PresidentP E R S O N A L I Z E
Reader Profile
P E R S O N A L I Z E
Celgene UK Assoc Dir, Medical Affairs
Cephalon Inc Director R&D
Cerner Corporation Genomics Strategist
Charite, Berlin, Germany Clinical Fellow
Children’s Cancer Institute Executive Director
Children’s Hosp. of Philadelphia Chair
Columbia Univ. Associate Research Scientist
Columbia Univ. Inst. for Cancer Genetics Director
Daiichi Sankyo Senior Director of Functional Genomics and Proteomics
Dana-Farber Cancer Inst. Clinical Fellow
Dana-Farber Cancer Inst. Associate Director
Deciphera Pharmaceuticals Chief Scientific Officer
Dicerna Pharmaceuticals Chief Scientific Officer
Eisai Inc. Director
Eisai Inc. Distinguished Scientist
Eli Lilly CSO
Eli Lilly Exec VP
Eli Lilly Senior Research Fellow
Fangsheng Pharmaceuticals CSO
FDA Biologist/Scientific Reviewer
FDA Investigator
FDA Medical Officer
Forma Therapeutics Senior Director; Pharmacology & Translational Biology
Forma Therapeutics Director Discovery Biology
Gan & Lee Pharmaceuticals Co., Ltd. CSO
Geisel School of Medicine Chair
Genentech Group Medical Director; USMA BioOncology
Genentech Sr. Manager; CDx
Genentech Inc. Assistant Medical Director
Genentech, Inc. Director
Genentech, Inc. Vice President- Hematology
Genetic Institute Acting lab director
Genetic Research Inst. Director
Genome Institute of Singapore Bioinformatics Specialist
Genome Institute of Singapore Senior Project Manager
Genome Technology Branch; NHGRI Senior Investigator
Genomic Health Doctor
Genomic Health Research Scientist
Genomics England CEO Genomics Enterprises
Georgetown Univ. School of Medicine Chair of Pathology
Georgetown University Director; Innovation Center for Biomedical Informatics
Gielad Sciences VP Biometrics
Glaxosmithkline Scientist
Glaxosmithkline Director, Oncology R&D
P E R S O N A L I Z E
Glaxosmithkline - Ware Director - Biophysical Sensors & Data Analytics
GSK VP
Halozyme Director Biotherapeutics Discovery
Halozyme Senior Medical Director
Hampton University Chair And Associate Professor
Henry Ford Health System Director; Molecular Pathology and Genomic Medicine
Hospital General de Mexico Medical Oncology
Human Longevity Senior VP
Icahn School of Medicine Clinical Fellow
Icahn School of Medicine at Mount Sinai Professor Emeritus
Imperial College London Professor of Chemical Biology
INC Research Executive Director; Clinical Dev; Early Phase Oncology
IncellDx Chief Business Officer/President
Incyte Corporation Principal Statistician
Inova Health System Director; Personalized Medicine Integration
Inova Health System Executive Vice President and Chief Technology Officer
Institut De Rechere Pierre Fabre Head of Translational Medicine
Janssen Research & Development VP & Global Head; Computational Sciences
Janssen Research & Development Associate Scientific Director
Janssen Research & Development Associate Scientific Director
Janssen Research & Development Global Head, Discovery Science
Johns Hopkins Medical Inst. Clinical Fellow
Keio University School of Medicine, Clinical Fellow
King’s College London Head Bioinformatics; NIHR BRC for Mental Health
Klaipeda University Hospital Head of Immunology Lab
Kolltan Pharmaceuticals Associate Director of Research
LSUHSC Cancer Center Director
Lytix Biopharma As Chief Medical Officer
Marshfield Clinic Research Foundation Director; CTR for Human Genetics
Massachusetts General Hospital Research Fellow
Mayo Clinic Director; Medical Genome Facility
Mayo Clinic Medical Director; Individualized Medicine
MD Anderson Cancer Center Medical Director; Laboratory Informatics
Medimmune Associate Director, R&D
Medimmune Vice President R&D
Medimmune Ltd. Director of Oncology Research
Merck Assoc. Director
Merck Associate Dir, Global Comm
Merck Clinical Director
Mirati Therapeutics President and CEO
Mission Health Director; Personalized Medicine
Mission Therapreutics VP Biology
Miyagi Cancer Ctr. Research Inst. Chief Res Fellow
P E R S O N A L I Z E
Moffitt Cancer Center EVP and Center Director
Moffitt Cancer Center Associate Center Director
Moffitt Cancer Center Center Director And Evp
Momenta Pharmaceuticals Vice President Research
Multi. Myeloma Research Foundation VP Translational Research
Myriad Genetics Inc. VP Medical Director Clinical Research
National Cancer Institute Deputy Director
National Cancer Institute Associate Chief
National Cancer Institute Biomedical Informatics
NIH Acting Director
NIH/NCI/CCR Director of Clinical Genomics
NNE Pharmaplan VP
NorthShore University Health System Division Head; Center for Medical Genetics
Northwestern University Assistant Director Clinical Services
Norwegian University Research Scientist
Novartis Global head of preclinical informatics
Novartis Assoc. Director
Novartis Institutes for Biomedical Research Global Head Oncology Bioinformatics
Novartis Oncology Associate Director
Novartis Oncology Group Lead
Novartis Director; Global Pipeline Diagnostic Strategy
Novartis Director of Clinical Research
Novartis Global Clinical Lead
Oncomed Pharmaceuticals, Inc. VP; Translational Medicine
Ontario Institute Director, Genome Technologies
Oregon Health & Science University Dir Computational Biology
Penn Medicine Clinical Director
Peter Maccallum Cancer Ctr. Director
Pfizer VP Enterprise Science & Technology
Pfizer VP Science Policy and Science Advocacy
Pfizer Chief of Staff, Global Oncolog
Pfizer Senior Director
Pfizer Associate Research Fellow
Pfizer Vice President
Princess Margaret Cancer Centre Director of Immune Therapy Program
Puma Biotechnology CEO
Queen’s Univ. Belfast Director
Quest Diagnostics Senior Cytogenetics Director
Quest Diagnostics VP Medical Affairs
Quintiles Head of Precision Medicine
Regeneron Pharmaceuticals Director Predictive Medicine; Translational Medicine
Regeneron Pharmaceuticals Executive Director
P E R S O N A L I Z E
Roche Head of Pharmacology
Roche Diagnostics GMBH Lab Head Genetics-Genomics
Rutgers- CINJ Associate Director Informatics
Rutgers-The Cancer Inst. of New Jersey Director of Precision Medicine
Sanford-Burnham Medical Research Inst. CEO
Sanofi Genzyme Sen. Director; Head Proteogenomics
Sanofi Onclogy Associate Vice-President
Sanofi R&D SVP Oncology
Seattle Genetics, Inc. Associate Dir, Cell Biology
Sequenom Vice President
St. Jude Children’s Res. Hosp. Chair
St. Jude Children’s Research Hospital Director; Division of Cancer Predisposition
Stanford Professor of Medicine and Genetics
Texas Tech University Chair
The Christ Hospital Director of Cancer Research
The Jackson Laboratory President and CEO
Thermofisher Scientific Director, Oncology R&D
Thomas Jefferson Univ. Chair And Professor
Tokai Pharmaceuticals Vice President; Head of Translational Medicine
Tokyo Medical University Chair And Professor
Trillium Therapeutics, Inc. Chief Medical Officer
University Medical Centre Groningen Professor of Medical Translational Genetics
Univ. of Maryland Greenebaum Cancer Ctr. Associate Director for Clinical Research
Univ. of Pennsylvania Chair
Univ. of Pennsylvania School of Medicine Director And Assoc. Professor
Univ. of Wisconsin Associate Research Specialist
University of Cambridge Academic Consultant in Experimental Cancer Therapeutics
University of Louisville Associate Professor/Research
University of Michigan Director Center for the Discovery of New Medicines
University of North Carolina Director; Center for Pharmacogenomics and Individualized Therapy
University of Oxford Clinical Director
MD Anderson Cancer Ctr. Fellow
Weill Cornell Med. College Associate Research Professor
Yale School of Medicine Assoc Professor of Medical Oncology
Job Profile
Research
Scientists
Clinical Scientists
BiomarkerR&D
Drug Discovery
Heads ofPathology
Heads of Research
Genetics
Directors of Precision Medicine
Drug SafetyHeads of
Translational Medicine
Heads of Clinical
R&D
Heads of Dx
Directors of Clinical
Trials
Computational
Heads of Experimental
Medicine
Proteomics
Genomics
Metabolomics
EpigenomicsMicrobiomics
IVD
Molecular
Companion
P E R S O N A L I Z E
ClinicalInformatics
Genetic Counselors
Head ofSequencing
ChiefMedicalOfficers
ResearchInformatics
‘Now that firm evidence exists for the diagnostic and clinical utility of genomic/precision medicine, there is a
strong need for a journal to help synthesize progress in this highly dynamic field.’
Print Rates
1/3 page $2,850 1/2 page $3,950 Full page $6,450 Double page spread $11,950 Outside back cover $9,950 Two Page Precision Profile $8,950
Impact pieces 4 page insert $9,150 2 page insert $7,050 Barn Door $12,450 Full page cover tip on $8,950 Belly wrap $12,500 Spreadmarker $12,500
P E R S O N A L I Z E
Stephen KingsmorePresident/CEO, Rady Pediatric Genomic and
Systems Medicine Institut
‘Successful implementation and incorporation of precision medicine in healthcare requires comprehensive and co-operative integration of scientists, government regulatory and policy makers, commercial stakeholders, payers and patients. A journal fully dedicated to Precision Medicine to cover these
issues is both timely and important.’
Online Rates
Email Blasts $450 per 1000 (minimum 3000 recipients) Email Blasts can be used to promote in house webinars, used as e-application notes, product launches, awareness of upcoming exhibitions or to promote video. We offer eTOC’s on a bimonthly basis
Mailing List Rental $200 per 1000 recipients
Webinars $12,000
We will produce, host and promote your webinar and will partner with you in sourcing Industry Opinion Leaders related to your area of technology/interest. We will arrange:- l Moderator. l Recording, promotion and rehearsal prior to the event. l Management of data capture through registration pre and post event. l On demand availability of webinar for 6 months. l Categorised in archive.
P E R S O N A L I Z E
Eric LaiSenior VP, Head of Pharmacogenomics & Companion Diagnostics,
Takeda Pharmaceuticals International, Inc.
Online Rates
Video $850 per month (Homepage)
Website Advertising
P E R S O N A L I Z E
Banner 11321 pxl x 240 pxl$950
Banner 2312 pxl x 802 pxl $750
Banner 3328 pxl x 482 pxl $550
Digital Media
The Journal of Precision Medicine has created an active environment on Linkedin and Twitter. Delivering our Snpits to an audience eager to learn more about this dynamic space, encouraging followers to engage in reading, sharing and participating in a continuous flow of dialogue, we aim to be an invaluable resource and platform to further discussion on the critical issues facing Pharma, Biotech and Diagnostic companies in the Personalised Precision Medicine landscape.
The Website offers new features and investigative snapshots of developments in the field of Precision Medicine. Our website is available at www.thejournalofprecisionmedicine.com and covers everything Precision Medicine from videos to news to interviews to editorial content - we also have an app on the App Store and will be on Google Play in 2017.
P E R S O N A L I Z E
P E R S O N A L I Z E
Specifications
Full Page
Half PageHorizontal
Half PageVertical
HalfIsland
ThirdVertical
ThirdIsland
ThirdHorizontal
Half Page Horizontal8”W x 4.75”H203mmW x 121mmH
Third Vertical2.57”W x 9.84”H65.5mmW x 250mmH
Half Island5.25”W x 7.375”H133mmW x 187mmH
Third Island5.25”W x 4.875”H133mmW x 124mmH
Third Horizontal8”W x 3”H203mmW x 76mmH
Half Page Vertical3.875”W x (9.84”H98mmW x 250mmH
Full Page9”W x 10.875”H Trim229mmW x 276mmH
9.25”W x 11.125”H Bleed235mmW x 283mmH
8.625”W x 10.5H Live Area
219mmW x 267mmH(Safe from Trim)
Double Page Spread
Double Page Spread18.5”W x 11.125”H (in bleed)
Belly Band19.25” x 5”D
Belly Band
P E R S O N A L I Z E
E-Newsletter dates for 2017
January 4th 11th
18th 25th
February 1st 8th
15th 22nd
March 1st 8th
15th 22nd29th
April 5th 12th
19th 26th
May 3rd 10th
17th 24th31st
June 7th 14th21st 28th
July 5th 12th
19th 26th
August 2nd 9th
16th 23rd30th
September 6th 13th
20th 27th
October 4th 11th
18th 25th
November 1st 8th
15th 22nd29th
December 6th 13th
20th 27th
Leaderboard $1000
Boom Box Advertisment
$750
SponsoredContent
$850
P E R S O N A L I Z E
GenomicsEpigeneticsMol DxProteomics
Transcriptomics
Companion Dx
Biomarkers
Genetic TestingGene Therapy
Clinical InformaticsDigital HealthSynthetic Biology
Clinical Chemistry
3D Bioprinting
Reimbursement
NEXT GENERATION SEQUENCING
Artificial IntelligenceRegenerative
MedicineLegal, Bioethical and Social Implications of Precision Medicine
Big Data
Drug Safety/Dosage
Gene Based Clinical Trials
Editorial Calendar for 2017
Precision Tools will cover a wide range of technologies and approaches critical to the success
of Precison Medicine. Here are some of the areas but not limited to, that we shall cover.
Cognoscienti will cover issues relating to bioethics, politics, regulation, policy, patient advocacy.
Field Notes is designed to expand upon some news centering around progress being made in
a particular therapeutic area.
SNPshot will cover an area of growing scientific or technological development.
The Hub will centre on an area of innovation around the globe that is promoting inward
investment and advancing science and technology in the pursuit of precision therapeutics.
We shall cover a broad range of topics in each issue, some of these are listed below.
P E R S O N A L I Z E
Editorial Features for 2017
Field Notes
Jan-Feb: Precision BioBanking
Mar-Apr: Rare Diseases
May-Jun: Oncology
July-Aug: Infectious Diseases
Sept-Oct: Neurodegenerative Diseases
Nov-Dec: Pediatric Diseases
2020
Jan-Feb: TBC
Mar-Apr: TBC
May-Jun: TBC
July-Aug: TBC
Sept-Oct: TBC
Nov-Dec: TBC
SNPshot
Jan-Feb: Microbiome
Mar-Apr: Big Data
May-June: NGS
July-Aug: Genomics
Sept-Oct: Digital Pathology
Nov-Dec: Pharmacogenomics
The Hub
Jan-Feb: Dublin, Ireland
Mar-Apr: Qatar
May-June: Stockholm
July-Aug: San Diego
Sept-Oct: Singapore
Nov-Dec: South Africa
Event Schedule
These are some of the conferences we will be attending or exhibiting at in 2017.
ACMG 22-24 March 2017 Phoenix, AZ
AACR 1-5 April 2017 Washington, DC
ASCO 3-7 June 2017 Chicago, IL
Bio International Convention 6-9 June 2017 San Diego, CA
AACC 30 July-3 August 2017 San Diego, CA
2nd Annual Precision Medicine Leaders Summit 21-24 August 2017 San Diego, CA
ASHG 17-21 October 2017 Orlando, FL
AMP 16-18 November 2017 Salt Lake City, UT
P E R S O N A L I Z E
Damian Doherty Co-Founder & Editor in ChiefThe Journal of Precision MedicineThe Atrium, Curtis Road, Dorking, Surrey RH4 1XA UKT: +44 (0)1306 646449 F: +44 (0)1306 471903E: ddoherty@thejournalofprecisionmedicine.comwww.thejournalofprecisionmedicine.comwww.pmls2017.com
Nigel Russell Co-Founder & PresidentThe Journal of Precision Medicine10388 Tremont Drive, Fishers, IN 46037 USAT: 317-762-7220 F: 317-863-1256nrussell@thejournalofprecisionmedicine.comwww.thejournalofprecisionmedicine.comwww.pmls2017.com
P E R S O N A L I Z E
Todd Hager Western US Sales ManagerThe Journal of Precision Medicine2446 NW Hemmingway Street Bend, OR 97703T: 541-350-5104 F: 317-863-1256E: thager@thejournalofprecisionmedicine.comwww.thejournalofprecisionmedicine.comwww.pmls2017.com